Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.43 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.72.
Market Cap
8.43T
Revenue
4.52T
Profits
207.07B
PE Ratio
40.72
Profit Margin
4.58%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 861.86B | 1.04% | 857,591 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 587.94B | 1.16% | 2,132,605 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 376.80B | 0.68% | 1,346,327 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 317.11B | 0.91% | 699,505 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 304.66B | 0.14% | 4,025,016 | 65.01B |
| 6 | NVS | Novartis AG | 292.80B | 0.99% | 508,086 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 279.04B | 0.47% | 3,022,505 | 447.57B |
| 8 | AMGN | Amgen Inc. | 193.52B | 2.50% | 1,514,473 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 187.16B | 0.03% | 542,120 | 44.56B |
| 10 | ABT | Abbott Laboratories | 179.15B | -0.68% | 2,367,476 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 177.28B | 0.91% | 1,803,189 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 166.69B | 0.05% | 6,939,529 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 162.63B | -0.95% | 724,983 | 10.06B |
| 14 | PFE | Pfizer Inc. | 155.97B | -0.18% | 12,353,551 | 62.58B |
| 15 | DHR | Danaher Corporation | 137.83B | -0.73% | 1,487,012 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.12B | -0.76% | 599,709 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.75B | 0.73% | 2,752,600 | 48.19B |
| 18 | GSK | GSK plc | 116.25B | 2.09% | 2,147,757 | 43.97B |
| 19 | SNY | Sanofi | 114.19B | 0.51% | 1,524,488 | 54.85B |
| 20 | HCA | HCA Healthcare, Inc. | 114.01B | 0.96% | 227,199 | 75.60B |
| 21 | MDT | Medtronic plc | 113.57B | -0.21% | 4,128,659 | 35.48B |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | 113.01B | 0.08% | 345,859 | 12.00B |
| 23 | MCK | McKesson Corporation | 107.52B | 0.76% | 277,842 | 397.96B |
| 24 | CVS | CVS Health Corporation | 101.32B | 0.34% | 1,872,677 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 91.10B | -2.01% | 6,389,819 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.77B | -1.02% | 244,299 | 14.34B |
| 27 | CI | The Cigna Group | 73.50B | 0.43% | 369,659 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.80B | -0.14% | 338,821 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.83B | -0.59% | 466,200 | 325.78B |
| 30 | MDLN | Medline Inc. | 59.93B | 2.89% | 2,438,520 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.06B | -0.43% | 1,707,106 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 51.15B | 1.03% | 387,586 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 50.75B | 0.39% | 900,819 | 9.47B |
| 34 | ARGX | argenx SE | 48.76B | 1.62% | 133,130 | 4.24B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.83B | -0.62% | 203,480 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 46.10B | -2.14% | 2,344,872 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 44.64B | -0.20% | 896,580 | 21.92B |
| 38 | HLN | Haleon plc | 43.61B | 0.45% | 2,901,742 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.87B | -1.23% | 429,892 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.63B | 0.67% | 728,164 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.91B | 1.05% | 1,668,780 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.07B | 1.31% | 37,998 | 5.34B |
| 43 | INSM | Insmed Incorporated | 34.54B | -0.12% | 692,380 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.37B | -0.83% | 1,626,640 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.11B | -1.06% | 470,785 | 5.40B |
| 46 | A | Agilent Technologies, Inc. | 32.80B | -0.74% | 413,372 | 7.07B |
| 47 | WAT | Waters Corporation | 31.20B | -0.16% | 219,212 | 3.17B |
| 48 | NTRA | Natera, Inc. | 28.60B | -4.27% | 744,455 | 2.31B |
| 49 | RPRX | Royalty Pharma plc | 28.02B | 1.42% | 911,261 | 2.38B |
| 50 | IQV | IQVIA Holdings Inc. | 28.01B | -3.28% | 990,260 | 16.31B |
| 51 | MTD | Mettler-Toledo International Inc. | 26.87B | 0.31% | 46,455 | 4.03B |
| 52 | PHG | Koninklijke Philips N.V. | 26.62B | 0.91% | 729,552 | 20.94B |
| 53 | BIIB | Biogen Inc. | 25.96B | -1.66% | 395,002 | 9.89B |
| 54 | VEEV | Veeva Systems Inc. | 25.72B | -5.45% | 2,742,265 | 3.20B |
| 55 | DXCM | DexCom, Inc. | 25.52B | 0.79% | 1,491,245 | 4.66B |
| 56 | UTHR | United Therapeutics Corporation | 25.37B | -0.48% | 152,440 | 3.18B |
| 57 | HUM | Humana Inc. | 23.90B | 0.36% | 531,166 | 129.66B |
| 58 | BNTX | BioNTech SE | 23.34B | 0.25% | 433,717 | 3.37B |
| 59 | LH | Labcorp Holdings Inc. | 22.66B | 0.08% | 137,781 | 13.95B |
| 60 | STE | STERIS plc | 21.97B | -0.43% | 192,916 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.96B | -0.21% | 168,040 | 11.04B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.35B | 0.92% | 1,268,795 | 13.31M |
| 63 | MRNA | Moderna, Inc. | 20.32B | -1.65% | 2,064,394 | 1.94B |
| 64 | RVMD | Revolution Medicines, Inc. | 19.38B | 1.07% | 595,489 | - |
| 65 | INCY | Incyte Corporation | 19.37B | 1.49% | 428,346 | 5.14B |
| 66 | ILMN | Illumina, Inc. | 19.06B | -2.59% | 1,100,641 | 4.34B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.90B | -1.32% | 304,643 | 3.07B |
| 68 | CNC | Centene Corporation | 18.38B | 0.27% | 1,324,979 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.10B | 0.53% | 595,561 | 8.23B |
| 70 | THC | Tenet Healthcare Corporation | 17.81B | 2.72% | 266,417 | 21.31B |
| 71 | GMAB | Genmab A/S | 17.17B | 0.42% | 1,503,836 | 3.72B |
| 72 | VTRS | Viatris Inc. | 15.87B | 0.41% | 2,269,854 | 14.30B |
| 73 | ASND | Ascendis Pharma A/S | 15.11B | 4.85% | 544,070 | 845.52M |
| 74 | SMMT | Summit Therapeutics Inc. | 14.99B | 2.76% | 919,101 | - |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.57B | 1.35% | 1,247,791 | 502.08M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.38B | -3.31% | 177,354 | 2.53B |
| 77 | SNN | Smith & Nephew plc | 14.07B | 0.79% | 670,322 | 6.16B |
| 78 | RGC | Regencell Bioscience Holdings Limited | 14.05B | -1.64% | 65,592 | - |
| 79 | PODD | Insulet Corporation | 14.04B | -0.37% | 297,923 | 2.71B |
| 80 | COO | The Cooper Companies, Inc. | 14.00B | 0.01% | 520,978 | 4.15B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.16B | -1.53% | 267,612 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.96B | -0.44% | 270,471 | 1.40B |
| 83 | IONS | Ionis Pharmaceuticals, Inc. | 12.70B | 2.51% | 468,360 | 943.71M |
| 84 | FMS | Fresenius Medical Care AG | 12.66B | 0.68% | 187,161 | 23.05B |
| 85 | ALGN | Align Technology, Inc. | 12.55B | -0.91% | 539,744 | 4.03B |
| 86 | GMED | Globus Medical, Inc. | 12.46B | 0.17% | 259,504 | 2.94B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.32B | 2.11% | 372,426 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.95B | 0.23% | 81,244 | 958.40M |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.91B | 1.53% | 2,190,835 | 4.72B |
| 90 | ENSG | The Ensign Group, Inc. | 11.91B | -0.44% | 103,340 | 5.06B |
| 91 | EXEL | Exelixis, Inc. | 11.73B | 2.15% | 721,531 | 2.32B |
| 92 | GH | Guardant Health, Inc. | 11.67B | -4.17% | 746,865 | 982.02M |
| 93 | SOLV | Solventum Corporation | 11.59B | 2.39% | 633,545 | 8.33B |
| 94 | UHS | Universal Health Services, Inc. | 11.56B | 1.29% | 127,702 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.92B | 0.23% | 1,039,604 | 3.85B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.91B | -0.84% | 351,899 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.84B | 2.05% | 306,390 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.10B | -0.08% | 335,564 | 2.86B |
| 99 | DVA | DaVita Inc. | 10.08B | 1.72% | 168,363 | 13.64B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.49B | 0.41% | 634,117 | 12.91B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.35B | 4.43% | 657,330 | 5.37M |
| 102 | MASI | Masimo Corporation | 9.32B | 0.16% | 355,790 | 1.53B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.19B | 2.02% | 657,093 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.17B | 3.48% | 270,590 | 638.50M |
| 105 | BAX | Baxter International Inc. | 9.02B | 1.33% | 1,867,546 | 11.24B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | 0.03% | 161,251 | 7.46M |
| 107 | PCVX | Vaxcyte, Inc. | 8.77B | 1.45% | 489,689 | - |
| 108 | HSIC | Henry Schein, Inc. | 8.75B | 1.05% | 309,172 | 13.18B |
| 109 | TECH | Bio-Techne Corporation | 8.73B | 1.12% | 920,944 | 1.22B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.53B | -1.01% | 433,281 | 4.02B |
| 111 | QGEN | Qiagen N.V. | 8.51B | -0.33% | 356,077 | 2.09B |
| 112 | ATR | AptarGroup, Inc. | 8.43B | 0.16% | 181,643 | 3.78B |
| 113 | NUVL | Nuvalent, Inc. | 8.21B | -0.53% | 186,333 | - |
| 114 | TEM | Tempus AI, Inc. | 8.11B | -4.46% | 3,274,881 | 1.27B |
| 115 | ICLR | ICON Public Limited Company | 8.01B | -1.52% | 382,674 | 8.10B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.00B | -1.19% | 405,534 | 88.04M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 7.97B | 2.86% | 435,981 | 1.40B |
| 118 | IBRX | ImmunityBio, Inc. | 7.69B | 6.66% | 15,498,458 | 113.29M |
| 119 | KRYS | Krystal Biotech, Inc. | 7.65B | -1.66% | 103,428 | 389.13M |
| 120 | MOH | Molina Healthcare, Inc. | 7.54B | -1.90% | 305,558 | 43.56B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.44B | -1.92% | 110,025 | 2.58B |
| 122 | BLTE | Belite Bio, Inc | 7.21B | 2.50% | 111,186 | - |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.20B | 1.27% | 163,253 | 39.21M |
| 124 | HQY | HealthEquity, Inc. | 7.08B | 2.27% | 545,586 | 1.31B |
| 125 | GKOS | Glaukos Corporation | 6.97B | 1.18% | 180,009 | 507.44M |
| 126 | GRFS | Grifols, S.A. | 6.83B | -4.77% | 839,585 | 8.83B |
| 127 | RGEN | Repligen Corporation | 6.76B | 0.11% | 214,003 | 738.26M |
| 128 | ACLX | Arcellx, Inc. | 6.73B | -0.01% | 227,316 | 22.29M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.64B | 1.98% | 238,373 | 46.02M |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.40B | 4.21% | 327,780 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.57% | 1,140,821 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.10% | 6,639,838 | - |
| 133 | COGT | Cogent Biosciences, Inc. | 6.02B | 1.24% | 1,489,152 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 2.78% | 263,557 | 189.76M |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 5.95B | 0.65% | 190,857 | 521.31M |
| 136 | CELC | Celcuity Inc. | 5.93B | 4.85% | 555,585 | - |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.92B | 0.36% | 321,010 | 1.73B |
| 138 | BLCO | Bausch + Lomb Corporation | 5.84B | -0.42% | 94,260 | 5.10B |
| 139 | BRKR | Bruker Corporation | 5.82B | -0.08% | 605,698 | 3.44B |
| 140 | ALKS | Alkermes plc | 5.81B | 0.46% | 802,614 | 1.48B |
| 141 | CGON | CG Oncology, Inc. | 5.75B | -1.07% | 397,510 | 4.04M |
| 142 | PACS | PACS Group, Inc. | 5.74B | 3.22% | 316,645 | 5.29B |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.62B | -2.08% | 765,372 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 5.60B | 1.98% | 371,416 | 7.50M |
| 145 | CHE | Chemed Corporation | 5.41B | -0.52% | 76,917 | 2.53B |
| 146 | ERAS | Erasca, Inc. | 5.37B | 2.07% | 1,879,406 | - |
| 147 | CAI | Caris Life Sciences, Inc. | 5.37B | -2.54% | 768,606 | 812.03M |
| 148 | LNTH | Lantheus Holdings, Inc. | 5.32B | 2.36% | 322,593 | 1.54B |
| 149 | AVTR | Avantor, Inc. | 5.31B | -1.88% | 2,883,938 | 6.55B |
| 150 | TFX | Teleflex Incorporated | 5.28B | 0.30% | 434,576 | 1.99B |
| 151 | IMVT | Immunovant, Inc. | 5.22B | 3.80% | 784,441 | - |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.01% | 4,370,534 | 1.00B |
| 153 | TGTX | TG Therapeutics, Inc. | 5.14B | 1.81% | 805,728 | 616.29M |
| 154 | CRSP | CRISPR Therapeutics AG | 4.99B | 0.35% | 529,567 | 3.51M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.80B | 3.59% | 229,819 | 2.04M |
| 156 | OPCH | Option Care Health, Inc. | 4.64B | 1.68% | 819,890 | 5.65B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,106,508 | 634.21M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.51B | 1.27% | 322,731 | 761.41M |
| 159 | HIMS | Hims & Hers Health, Inc. | 4.40B | -0.46% | 8,222,794 | 2.35B |
| 160 | NVST | Envista Holdings Corporation | 4.39B | 0.41% | 1,052,910 | 2.72B |
| 161 | SHC | Sotera Health Company | 4.35B | 0.39% | 764,991 | 1.16B |
| 162 | RDNT | RadNet, Inc. | 4.35B | 0.19% | 279,425 | 2.04B |
| 163 | ALHC | Alignment Healthcare, Inc. | 4.35B | -0.19% | 747,876 | 3.95B |
| 164 | OSCR | Oscar Health, Inc. | 4.29B | -1.37% | 3,155,789 | 11.70B |
| 165 | WAY | Waystar Holding Corp. | 4.24B | -2.38% | 1,367,464 | 1.10B |
| 166 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.17B | -0.38% | 376,876 | 7.70M |
| 167 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | 0.34% | 175,194 | 268.09M |
| 168 | SYRE | Spyre Therapeutics, Inc. | 4.13B | 1.17% | 310,698 | - |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.11B | -0.06% | 276,814 | 1.52B |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 4.11B | 1.34% | 357,058 | 3.02B |
| 171 | NAMS | NewAmsterdam Pharma Company N.V. | 4.01B | 2.62% | 179,149 | 22.50M |
| 172 | VKTX | Viking Therapeutics, Inc. | 3.97B | 1.84% | 855,654 | - |
| 173 | BLLN | BillionToOne, Inc. | 3.92B | -7.38% | 317,707 | 305.11M |
| 174 | DOCS | Doximity, Inc. | 3.90B | -3.29% | 1,945,148 | 637.78M |
| 175 | GPCR | Structure Therapeutics Inc. | 3.90B | 3.71% | 253,684 | - |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 0.04% | 571,641 | 1.07B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.84B | -1.26% | 136,805 | 747.14M |
| 178 | MMED | Minimed Group, Inc. | 3.81B | - | 519,641 | 2.89B |
| 179 | TMDX | TransMedics Group, Inc. | 3.80B | 1.31% | 311,834 | 605.49M |
| 180 | STVN | Stevanato Group S.p.A. | 3.76B | -0.22% | 133,908 | 1.39B |
| 181 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.57B | -0.70% | 365,203 | 677.56M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | 0.12% | 262,018 | - |
| 183 | LQDA | Liquidia Corporation | 3.54B | 5.08% | 580,884 | 158.32M |
| 184 | LIVN | LivaNova PLC | 3.51B | -0.87% | 240,719 | 1.39B |
| 185 | LEGN | Legend Biotech Corporation | 3.42B | 1.12% | 918,592 | 1.03B |
| 186 | BKD | Brookdale Senior Living Inc. | 3.34B | -0.39% | 1,998,761 | 3.05B |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.27B | 0.72% | 78,926 | 803.79M |
| 188 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.14B | 1.58% | 540,458 | 588.99M |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.14B | 3.48% | 1,017,846 | - |
| 190 | DNLI | Denali Therapeutics Inc. | 3.13B | 0.46% | 399,173 | - |
| 191 | ORKA | Oruka Therapeutics, Inc. | 3.11B | 1.24% | 428,121 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.10B | 0.15% | 94,582 | 2.23B |
| 193 | ARQT | Arcutis Biotherapeutics, Inc. | 3.10B | 1.54% | 400,827 | 376.07M |
| 194 | TARS | Tarsus Pharmaceuticals, Inc. | 3.08B | 0.80% | 94,232 | 451.36M |
| 195 | TWST | Twist Bioscience Corporation | 3.06B | -2.58% | 290,937 | 391.56M |
| 196 | SUPN | Supernus Pharmaceuticals, Inc. | 3.01B | 1.16% | 92,778 | 718.95M |
| 197 | ITGR | Integer Holdings Corporation | 2.96B | -0.57% | 113,729 | 1.85B |
| 198 | TNGX | Tango Therapeutics, Inc. | 2.92B | 2.14% | 1,153,532 | 62.38M |
| 199 | TXG | 10x Genomics, Inc. | 2.90B | -1.26% | 1,018,908 | 642.82M |
| 200 | VERA | Vera Therapeutics, Inc. | 2.90B | 0.84% | 629,599 | - |
| 201 | ALMS | Alumis Inc. | 2.88B | -0.18% | 447,155 | 24.05M |
| 202 | RCUS | Arcus Biosciences, Inc. | 2.88B | 1.55% | 149,860 | 247.00M |
| 203 | TVTX | Travere Therapeutics, Inc. | 2.88B | -1.48% | 757,379 | 490.73M |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.88B | 2.33% | 140,597 | 2.16B |
| 205 | HNGE | Hinge Health, Inc. | 2.87B | -4.67% | 405,775 | 587.86M |
| 206 | PRVA | Privia Health Group, Inc. | 2.87B | 0.66% | 790,910 | 2.12B |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 2.75B | 0.97% | 599,328 | 218.71M |
| 208 | NHC | National HealthCare Corporation | 2.74B | 1.91% | 87,167 | 1.52B |
| 209 | HAE | Haemonetics Corporation | 2.74B | -1.13% | 165,462 | 1.32B |
| 210 | ELVN | Enliven Therapeutics, Inc. | 2.72B | 5.87% | 975,462 | - |
| 211 | SLNO | Soleno Therapeutics, Inc. | 2.71B | -0.30% | 3,785,406 | 190.41M |
| 212 | PBH | Prestige Consumer Healthcare Inc. | 2.68B | 2.12% | 203,452 | 1.10B |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.64B | 3.98% | 301,320 | 1.55M |
| 214 | BEAM | Beam Therapeutics Inc. | 2.64B | 4.40% | 1,256,612 | 139.74M |
| 215 | RLAY | Relay Therapeutics, Inc. | 2.63B | 1.45% | 1,568,507 | 15.36M |
| 216 | KOD | Kodiak Sciences Inc. | 2.59B | 0.50% | 240,046 | - |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.57B | 6.31% | 1,442,515 | 3.31B |
| 218 | LMAT | LeMaitre Vascular, Inc. | 2.57B | 0.28% | 33,874 | 249.60M |
| 219 | WRBY | Warby Parker Inc. | 2.57B | -1.60% | 792,461 | 871.91M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 1.10% | 169,411 | 1.45B |
| 221 | LFST | LifeStance Health Group, Inc. | 2.54B | -0.31% | 740,173 | 1.42B |
| 222 | IRON | Disc Medicine, Inc. | 2.54B | 0.45% | 57,292 | - |
| 223 | IMNM | Immunome, Inc. | 2.51B | 2.12% | 456,220 | 6.94M |
| 224 | VCYT | Veracyte, Inc. | 2.50B | -3.55% | 170,384 | 517.15M |
| 225 | HCM | HUTCHMED (China) Limited | 2.48B | 2.27% | 17,094 | 548.51M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | 0.56% | 2,477,915 | 874.84M |
| 227 | ADMA | ADMA Biologics, Inc. | 2.40B | 2.70% | 1,989,335 | 510.17M |
| 228 | PAHC | Phibro Animal Health Corporation | 2.40B | 1.03% | 89,514 | 1.46B |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.38B | -0.38% | 1,587,637 | 3.68B |
| 230 | ZLAB | Zai Lab Limited | 2.36B | -1.96% | 672,202 | 460.16M |
| 231 | SRPT | Sarepta Therapeutics, Inc. | 2.35B | 2.18% | 933,181 | 2.20B |
| 232 | HTFL | HeartFlow, Inc. | 2.35B | 1.00% | 708,064 | 176.03M |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 2.59% | 695,788 | 673.00M |
| 234 | AAPG | Ascentage Pharma Group International | 2.32B | -5.69% | 1,182 | 82.08M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -0.22% | 300,803 | - |
| 236 | MANE | Veradermics, Incorporated | 2.25B | 3.70% | 73,698 | - |
| 237 | NKTR | Nektar Therapeutics | 2.23B | 3.49% | 263,521 | 55.23M |
| 238 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.12% | 413,276 | 158.18M |
| 239 | SNDX | Syndax Pharmaceuticals, Inc. | 2.19B | 0.90% | 304,946 | 172.35M |
| 240 | NEOG | Neogen Corporation | 2.18B | -3.19% | 3,239,480 | 870.56M |
| 241 | ADPT | Adaptive Biotechnologies Corporation | 2.14B | -6.20% | 863,589 | 276.98M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 1.32% | 303,284 | 283.06M |
| 243 | DFTX | Definium Therapeutics, Inc. | 2.14B | 2.09% | 730,170 | - |
| 244 | STOK | Stoke Therapeutics, Inc. | 2.09B | 1.38% | 273,394 | 184.42M |
| 245 | SEM | Select Medical Holdings Corporation | 2.03B | 0.09% | 262,566 | 5.45B |
| 246 | ZYME | Zymeworks Inc. | 2.01B | 2.27% | 170,825 | 105.97M |
| 247 | GRAL | GRAIL, Inc. | 2.01B | -3.58% | 353,549 | 147.17M |
| 248 | TYRA | Tyra Biosciences, Inc. | 1.99B | -0.30% | 493,820 | - |
| 249 | BHC | Bausch Health Companies Inc. | 1.98B | 0.09% | 513,436 | 10.27B |
| 250 | ANAB | AnaptysBio, Inc. | 1.96B | 4.10% | 172,776 | 234.60M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 1.95B | 6.41% | 3,034,855 | 51.95M |
| 252 | AHG | Akso Health Group | 1.94B | -1.17% | 143,169 | 14.84M |
| 253 | AGIO | Agios Pharmaceuticals, Inc. | 1.92B | -2.99% | 268,370 | 54.03M |
| 254 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | 1.06% | 532,832 | -665.00K |
| 255 | GLPG | Galapagos NV | 1.89B | -0.87% | 78,152 | 1.31B |
| 256 | PVLA | Palvella Therapeutics, Inc. | 1.88B | 6.77% | 243,109 | - |
| 257 | MESO | Mesoblast Limited | 1.85B | 6.25% | 249,359 | 65.38M |
| 258 | CAPR | Capricor Therapeutics, Inc. | 1.83B | 0.57% | 277,758 | 11.13M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 1.81B | -0.31% | 172,386 | 211.08M |
| 260 | WGS | GeneDx Holdings Corp. | 1.80B | -6.13% | 584,687 | 427.54M |
| 261 | PHVS | Pharvaris N.V. | 1.79B | -0.60% | 34,401 | - |
| 262 | INVA | Innoviva, Inc. | 1.78B | 1.95% | 269,796 | 411.33M |
| 263 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | -0.59% | 4,687,142 | 74.68M |
| 264 | AXGN | Axogen, Inc. | 1.77B | 0.59% | 302,829 | 225.21M |
| 265 | SION | Sionna Therapeutics, Inc. | 1.76B | 6.04% | 213,654 | - |
| 266 | AORT | Artivion, Inc. | 1.76B | 0.55% | 125,120 | 441.33M |
| 267 | OGN | Organon & Co. | 1.75B | 14.85% | 5,200,670 | 6.22B |
| 268 | MD | Pediatrix Medical Group, Inc. | 1.74B | 0.14% | 149,890 | 1.91B |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.73B | 3.21% | 597,151 | - |
| 270 | VCEL | Vericel Corporation | 1.72B | -0.48% | 95,986 | 276.26M |
| 271 | ATEC | Alphatec Holdings, Inc. | 1.71B | -3.09% | 578,461 | 764.16M |
| 272 | ADUS | Addus HomeCare Corporation | 1.69B | 0.69% | 179,393 | 1.42B |
| 273 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | 2.00% | 166,686 | 868.45M |
| 274 | NRIX | Nurix Therapeutics, Inc. | 1.68B | 3.85% | 326,255 | 71.78M |
| 275 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | 1.42% | 102,937 | 883.37M |
| 276 | SGRY | Surgery Partners, Inc. | 1.66B | 2.53% | 324,501 | 3.31B |
| 277 | AHCO | AdaptHealth Corp. | 1.65B | -0.08% | 430,004 | 3.24B |
| 278 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -0.22% | 762,886 | 67.67M |
| 279 | RAPP | Rapport Therapeutics, Inc. | 1.63B | 1.48% | 59,571 | - |
| 280 | INSP | Inspire Medical Systems, Inc. | 1.63B | 6.13% | 1,124,040 | 911.98M |
| 281 | OCS | Oculis Holding AG | 1.62B | 0.22% | 54,289 | 1.51M |
| 282 | OMCL | Omnicell, Inc. | 1.62B | 0.06% | 98,788 | 1.18B |
| 283 | IMCR | Immunocore Holdings plc | 1.61B | -0.47% | 112,081 | 400.02M |
| 284 | UFPT | UFP Technologies, Inc. | 1.59B | 2.74% | 117,473 | 602.80M |
| 285 | NUVB | Nuvation Bio Inc. | 1.59B | 2.10% | 1,178,773 | 62.90M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.57B | 1.91% | 92,747 | - |
| 287 | VIR | Vir Biotechnology, Inc. | 1.56B | 2.73% | 971,140 | 68.56M |
| 288 | VRDN | Viridian Therapeutics, Inc. | 1.56B | 5.67% | 1,532,174 | 70.85M |
| 289 | IOVA | Iovance Biotherapeutics, Inc. | 1.56B | 8.93% | 15,479,613 | 263.50M |
| 290 | MBX | MBX Biosciences, Inc. | 1.55B | 2.75% | 208,882 | - |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.54B | 0.69% | 271,541 | 336.39M |
| 292 | SVRA | Savara Inc. | 1.49B | -1.01% | 283,535 | - |
| 293 | PGEN | Precigen, Inc. | 1.49B | 1.94% | 1,088,335 | 9.68M |
| 294 | ARDX | Ardelyx, Inc. | 1.49B | -0.66% | 1,129,717 | 407.32M |
| 295 | GENB | Generate Biomedicines, Inc. | 1.48B | -2.60% | 108,364 | 31.89M |
| 296 | PRGO | Perrigo Company plc | 1.47B | -1.29% | 805,134 | 4.25B |
| 297 | NBTX | Nanobiotix S.A. | 1.46B | -2.24% | 56,437 | 38.27M |
| 298 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 5.74% | 362,990 | - |
| 299 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | -0.30% | 477,780 | 2.43B |
| 300 | GLUE | Monte Rosa Therapeutics, Inc. | 1.43B | 4.61% | 317,058 | 123.67M |
| 301 | ATRC | AtriCure, Inc. | 1.43B | -0.14% | 233,706 | 534.53M |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.43B | 0.79% | 240,656 | - |
| 303 | BHVN | Biohaven Ltd. | 1.42B | 0.85% | 451,181 | - |
| 304 | IMTX | Immatics N.V. | 1.42B | 0.57% | 109,062 | 56.67M |
| 305 | ASTH | Astrana Health, Inc. | 1.40B | 3.43% | 142,253 | 3.18B |
| 306 | NVAX | Novavax, Inc. | 1.40B | 1.78% | 1,212,924 | 1.12B |
| 307 | HROW | Harrow, Inc. | 1.39B | 1.88% | 107,279 | 272.30M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.39B | -0.68% | 381,510 | 2.50M |
| 309 | ENOV | Enovis Corporation | 1.38B | 0.63% | 158,932 | 2.25B |
| 310 | MLTX | MoonLake Immunotherapeutics | 1.37B | 2.58% | 739,787 | - |
| 311 | ATAI | AtaiBeckley Inc. | 1.37B | -0.27% | 1,079,997 | 4.09M |
| 312 | ARDT | Ardent Health, Inc. | 1.36B | 2.36% | 83,564 | 6.32B |
| 313 | TNDM | Tandem Diabetes Care, Inc. | 1.36B | 2.43% | 328,649 | 1.01B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.36B | 0.49% | 176,142 | 1.84B |
| 315 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.85% | 1,120,762 | 42.73M |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.35B | 0.08% | 290,581 | 308.05M |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 2.75% | 593,558 | 9.77M |
| 318 | PGNY | Progyny, Inc. | 1.31B | -1.06% | 290,240 | 1.29B |
| 319 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | 4.47% | 226,854 | - |
| 320 | PLSE | Pulse Biosciences, Inc. | 1.30B | 0.42% | 90,095 | 350.00K |
| 321 | STAA | STAAR Surgical Company | 1.29B | 25.10% | 4,252,564 | 239.44M |
| 322 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 2.42% | 221,233 | 10.00M |
| 323 | NVCR | NovoCure Limited | 1.24B | 1.11% | 300,958 | 655.35M |
| 324 | IRMD | IRADIMED CORPORATION | 1.23B | -1.35% | 60,711 | 83.81M |
| 325 | PHAR | Pharming Group N.V. | 1.20B | 1.12% | 437 | 376.13M |
| 326 | EYPT | EyePoint, Inc. | 1.19B | 1.06% | 354,072 | 31.37M |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.19B | 6.61% | 673,815 | - |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.19B | 11.39% | 173,751 | - |
| 329 | DBVT | DBV Technologies S.A. | 1.19B | -0.28% | 76,009 | 5.64M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 1.94% | 47,277 | 773.34M |
| 331 | NNNN | Anbio Biotechnology | 1.17B | -1.26% | 15,221 | 8.65M |
| 332 | INNV | InnovAge Holding Corp. | 1.16B | 2.51% | 131,090 | 915.37M |
| 333 | CNMD | CONMED Corporation | 1.16B | 2.43% | 102,791 | 1.37B |
| 334 | ALVO | Alvotech | 1.14B | 1.82% | 181,007 | 588.90M |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.13B | -1.02% | 120,389 | 83.72M |
| 336 | SEPN | Septerna, Inc. | 1.13B | 2.45% | 73,739 | 45.95M |
| 337 | INBX | Inhibrx Biosciences, Inc. | 1.12B | 14.66% | 288,377 | 1.30M |
| 338 | PNTG | The Pennant Group, Inc. | 1.11B | 2.19% | 37,581 | 947.71M |
| 339 | COLL | Collegium Pharmaceutical, Inc. | 1.10B | 4.07% | 279,138 | 780.57M |
| 340 | GERN | Geron Corporation | 1.10B | 0.58% | 12,347,417 | 183.88M |
| 341 | BFLY | Butterfly Network, Inc. | 1.05B | -0.85% | 1,606,612 | 97.61M |
| 342 | ABCL | AbCellera Biologics Inc. | 1.04B | - | 869,813 | 75.13M |
| 343 | NEO | NeoGenomics, Inc. | 1.04B | -3.04% | 471,849 | 727.33M |
| 344 | QURE | uniQure N.V. | 1.03B | 3.71% | 510,442 | 16.10M |
| 345 | AZTA | Azenta, Inc. | 1.03B | 0.31% | 334,413 | 595.03M |
| 346 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | 0.93% | 993,605 | 291.85M |
| 347 | EVMN | Evommune, Inc. | 1.02B | 4.79% | 113,283 | 13.00M |
| 348 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 3.32% | 143,001 | 73.62M |
| 349 | IVA | Inventiva S.A. | 1.02B | 1.89% | 170,035 | 9.31M |
| 350 | CLOV | Clover Health Investments, Corp. | 1.01B | 0.26% | 1,177,175 | 1.92B |
| 351 | ORIC | ORIC Pharmaceuticals, Inc. | 999.07M | 10.00% | 1,233,770 | - |
| 352 | CMPX | Compass Therapeutics, Inc. | 997.69M | 2.59% | 675,802 | 850.00K |
| 353 | BLFS | BioLife Solutions, Inc. | 989.18M | 3.91% | 177,396 | 96.21M |
| 354 | QDEL | QuidelOrtho Corporation | 987.19M | -5.35% | 879,385 | 2.73B |
| 355 | URGN | UroGen Pharma Ltd. | 986.30M | 6.07% | 782,551 | 109.79M |
| 356 | AKTS | Aktis Oncology, Inc. | 985.85M | 5.04% | 135,013 | 6.50M |
| 357 | ANNX | Annexon, Inc. | 982.91M | 1.24% | 507,924 | - |
| 358 | PHAT | Phathom Pharmaceuticals, Inc. | 982.55M | 4.74% | 604,154 | 175.11M |
| 359 | EVO | Evotec SE | 969.55M | -1.54% | 12,369 | 925.65M |
| 360 | CRON | Cronos Group Inc. | 966.26M | 0.79% | 548,423 | 146.59M |
| 361 | PCRX | Pacira BioSciences, Inc. | 962.85M | 2.28% | 78,864 | 726.41M |
| 362 | AMPH | Amphastar Pharmaceuticals, Inc. | 957.31M | 3.43% | 156,477 | 719.89M |
| 363 | GHRS | GH Research PLC | 950.60M | 2.23% | 18,797 | - |
| 364 | TDOC | Teladoc Health, Inc. | 933.91M | -0.66% | 2,483,415 | 2.53B |
| 365 | CTMX | CytomX Therapeutics, Inc. | 917.67M | -0.12% | 1,027,067 | 76.20M |
| 366 | SLS | SELLAS Life Sciences Group, Inc. | 917.67M | 5.14% | 3,521,958 | - |
| 367 | SSII | SS Innovations International, Inc. | 912.73M | 6.16% | 17,042 | 42.48M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 909.41M | 0.43% | 221,197 | - |
| 369 | OPK | OPKO Health, Inc. | 899.49M | -0.42% | 807,763 | 606.88M |
| 370 | XNCR | Xencor, Inc. | 899.13M | 0.08% | 155,599 | 125.58M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 899.11M | -1.73% | 235,337 | 1.02B |
| 372 | JBIO | Jade Biosciences, Inc. | 896.08M | 8.41% | 773,477 | - |
| 373 | FTRE | Fortrea Holdings Inc. | 884.51M | -1.77% | 335,315 | 2.72B |
| 374 | JANX | Janux Therapeutics, Inc. | 883.88M | - | 208,019 | 10.00M |
| 375 | INMD | InMode Ltd. | 872.45M | -0.07% | 274,814 | 370.50M |
| 376 | VOR | Vor Biopharma Inc. | 865.34M | 1.43% | 535,750 | - |
| 377 | TALK | Talkspace, Inc. | 862.95M | 0.10% | 858,239 | 228.87M |
| 378 | SANA | Sana Biotechnology, Inc. | 857.98M | 0.16% | 598,634 | - |
| 379 | CDNA | CareDx, Inc. | 854.29M | -6.92% | 404,527 | 379.81M |
| 380 | TBPH | Theravance Biopharma, Inc. | 852.72M | -0.24% | 102,369 | 107.46M |
| 381 | OMER | Omeros Corporation | 845.96M | 2.09% | 638,731 | - |
| 382 | SPRY | ARS Pharmaceuticals, Inc. | 841.05M | 3.42% | 1,265,181 | 84.28M |
| 383 | SDGR | Schrödinger, Inc. | 838.65M | -1.22% | 738,257 | 255.87M |
| 384 | ABUS | Arbutus Biopharma Corporation | 832.74M | -2.74% | 910,344 | 14.08M |
| 385 | CERT | Certara, Inc. | 814.16M | -2.21% | 1,770,809 | 418.84M |
| 386 | MNKD | MannKind Corporation | 810.30M | 0.77% | 1,192,094 | 348.97M |
| 387 | SLDB | Solid Biosciences Inc. | 805.82M | 2.12% | 286,511 | - |
| 388 | DRUG | Bright Minds Biosciences Inc. | 805.65M | 1.44% | 126,772 | - |
| 389 | MRVI | Maravai LifeSciences Holdings, Inc. | 798.19M | -0.16% | 924,676 | 185.74M |
| 390 | TLRY | Tilray Brands, Inc. | 797.90M | 1.70% | 1,740,495 | 858.28M |
| 391 | RLMD | Relmada Therapeutics, Inc. | 787.71M | 7.13% | 1,061,021 | - |
| 392 | BIOA | BioAge Labs, Inc. | 785.52M | -1.88% | 108,767 | 9.00M |
| 393 | KURA | Kura Oncology, Inc. | 780.84M | 0.57% | 266,994 | 67.48M |
| 394 | LXRX | Lexicon Pharmaceuticals, Inc. | 775.34M | 9.58% | 2,376,374 | 49.80M |
| 395 | DSGN | Design Therapeutics, Inc. | 773.99M | -0.95% | 77,935 | - |
| 396 | MGTX | MeiraGTx Holdings plc | 769.67M | 0.64% | 156,296 | 81.39M |
| 397 | BVS | Bioventus Inc. | 759.20M | -0.11% | 159,496 | 568.09M |
| 398 | TENX | Tenax Therapeutics, Inc. | 756.01M | -0.13% | 515,793 | - |
| 399 | IART | Integra LifeSciences Holdings Corporation | 752.09M | 0.31% | 154,303 | 1.64B |
| 400 | NUTX | Nutex Health Inc. | 745.27M | 1.82% | 117,594 | 875.26M |
| 401 | GDRX | GoodRx Holdings, Inc. | 738.25M | 0.70% | 560,051 | 796.85M |
| 402 | ETON | Eton Pharmaceuticals, Inc. | 728.50M | 1.16% | 137,179 | 79.95M |
| 403 | CMPS | COMPASS Pathways plc | 728.42M | -1.22% | 508,202 | - |
| 404 | ARVN | Arvinas, Inc. | 723.40M | 0.89% | 222,418 | 262.60M |
| 405 | SGP | SpyGlass Pharma, Inc. | 718.67M | -3.24% | 37,203 | - |
| 406 | CSTL | Castle Biosciences, Inc. | 715.33M | -4.49% | 69,318 | 344.23M |
| 407 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 714.69M | 3.36% | 186,440 | - |
| 408 | AMN | AMN Healthcare Services, Inc. | 714.17M | -2.66% | 337,668 | 2.73B |
| 409 | ANRO | Alto Neuroscience, Inc. | 712.54M | 2.74% | 83,140 | - |
| 410 | EHAB | Enhabit, Inc. | 709.62M | - | 312,365 | 1.06B |
| 411 | CBLL | CeriBell, Inc. | 706.53M | 0.48% | 62,322 | 89.06M |
| 412 | OMDA | Omada Health, Inc. | 697.68M | -5.51% | 261,891 | 260.21M |
| 413 | ALLO | Allogene Therapeutics, Inc. | 689.89M | 4.81% | 2,634,140 | 22.00K |
| 414 | LBRX | LB Pharmaceuticals Inc | 662.58M | 0.81% | 194,720 | - |
| 415 | AVNS | Avanos Medical, Inc. | 658.55M | 1.72% | 130,240 | 701.20M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 657.46M | 1.55% | 15,557 | 116.59M |
| 417 | OCGN | Ocugen, Inc. | 647.07M | 2.96% | 2,957,639 | 4.41M |
| 418 | DRTS | Alpha Tau Medical Ltd. | 640.71M | 1.11% | 172,730 | - |
| 419 | PSNL | Personalis, Inc. | 632.25M | -4.58% | 1,073,882 | 69.65M |
| 420 | FBRX | Forte Biosciences, Inc. | 630.43M | 27.86% | 1,913,110 | - |
| 421 | PRME | Prime Medicine, Inc. | 625.09M | -0.28% | 610,568 | 4.63M |
| 422 | CBIO | Crescent Biopharma, Inc. | 617.78M | 1.53% | 53,800 | 10.84M |
| 423 | SIBN | SI-BONE, Inc. | 600.65M | -2.37% | 800,317 | 200.93M |
| 424 | CTKB | Cytek Biosciences, Inc. | 593.26M | -0.97% | 202,613 | 201.49M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 588.64M | 2.85% | 577,518 | 296.15M |
| 426 | MDXG | MiMedx Group, Inc. | 588.32M | -0.25% | 434,077 | 418.63M |
| 427 | HSTM | HealthStream, Inc. | 588.01M | -1.48% | 73,451 | 304.06M |
| 428 | CRMD | CorMedix Inc. | 580.23M | 1.52% | 331,410 | 311.71M |
| 429 | ESPR | Esperion Therapeutics, Inc. | 577.82M | -3.43% | 4,579,970 | 403.14M |
| 430 | PROK | ProKidney Corp. | 573.64M | 2.70% | 181,256 | 893.00K |
| 431 | PRTA | Prothena Corporation plc | 573.05M | -0.05% | 132,532 | 9.68M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 570.09M | 1.25% | 273,882 | 106.47M |
| 433 | TECX | Tectonic Therapeutic, Inc. | 567.81M | 0.60% | 67,101 | - |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 563.24M | 2.56% | 151,990 | 294.28M |
| 435 | KYTX | Kyverna Therapeutics, Inc. | 561.63M | 0.76% | 389,527 | - |
| 436 | LYEL | Lyell Immunopharma, Inc. | 554.98M | 3.84% | 68,170 | 36.00K |
| 437 | UPB | Upstream Bio, Inc. | 553.45M | 3.35% | 405,986 | 2.85M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 552.51M | 0.63% | 499,211 | 7.83M |
| 439 | BWAY | BrainsWay Ltd. | 549.92M | 8.84% | 179,952 | 52.23M |
| 440 | VALN | Valneva SE | 546.53M | -0.40% | 12,467 | 205.07M |
| 441 | TCMD | Tactile Systems Technology, Inc. | 545.55M | -0.66% | 124,972 | 329.52M |
| 442 | ZURA | Zura Bio Limited | 540.82M | - | 311,488 | - |
| 443 | STTK | Shattuck Labs, Inc. | 539.59M | 7.41% | 688,367 | 1.00M |
| 444 | LRMR | Larimar Therapeutics, Inc. | 530.32M | 0.29% | 539,364 | - |
| 445 | FULC | Fulcrum Therapeutics, Inc. | 529.80M | 0.70% | 310,439 | 80.00M |
| 446 | EMBC | Embecta Corp. | 525.87M | - | 239,960 | 1.08B |
| 447 | IMMX | Immix Biopharma, Inc. | 524.29M | 13.03% | 606,036 | - |
| 448 | AVR | Anteris Technologies Global Corp. | 516.34M | 2.21% | 256,731 | 1.91M |
| 449 | REPL | Replimune Group, Inc. | 516.08M | 6.20% | 5,049,434 | - |
| 450 | AQST | Aquestive Therapeutics, Inc. | 510.76M | 0.12% | 361,265 | 44.55M |
| 451 | PHR | Phreesia, Inc. | 506.76M | -4.69% | 895,297 | 480.59M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 503.88M | -2.28% | 172,911 | 85.21M |
| 454 | CATX | Perspective Therapeutics, Inc. | 502.45M | 0.92% | 194,079 | 884.00K |
| 455 | OFIX | Orthofix Medical Inc. | 500.60M | 2.21% | 101,261 | 822.31M |
| 456 | TRDA | Entrada Therapeutics, Inc. | 498.96M | -3.21% | 51,120 | 25.42M |
| 457 | NPCE | NeuroPace, Inc. | 498.94M | 0.14% | 36,243 | 99.99M |
| 458 | EIKN | Eikon Therapeutics, Inc. | 498.35M | -3.11% | 126,627 | - |
| 459 | AGMB | AgomAb Therapeutics NV | 496.63M | 3.45% | 164,148 | - |
| 460 | VSTM | Verastem, Inc. | 492.75M | 2.94% | 627,086 | 30.91M |
| 461 | IVVD | Invivyd, Inc. | 487.84M | 27.78% | 8,978,973 | 53.43M |
| 462 | ENGN | enGene Holdings Inc. | 487.68M | -0.41% | 95,593 | - |
| 463 | LXEO | Lexeo Therapeutics, Inc. | 483.05M | 1.24% | 264,446 | - |
| 464 | KMDA | Kamada Ltd. | 481.97M | 0.53% | 20,437 | 180.46M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 480.89M | 0.70% | 60,047 | - |
| 466 | ASMB | Assembly Biosciences, Inc. | 478.42M | 2.76% | 65,408 | 72.30M |
| 467 | ADCT | ADC Therapeutics SA | 477.69M | 0.80% | 269,289 | 81.36M |
| 468 | VTVT | vTv Therapeutics Inc. | 471.44M | -1.22% | 43,566 | 17.00K |
| 469 | AVIR | Atea Pharmaceuticals, Inc. | 466.08M | -1.35% | 74,355 | - |
| 470 | ABSI | Absci Corporation | 461.36M | 0.84% | 1,560,526 | 2.80M |
| 471 | VREX | Varex Imaging Corporation | 461.32M | -0.32% | 64,558 | 854.40M |
| 472 | RGNX | REGENXBIO Inc. | 460.43M | 2.88% | 187,592 | 170.44M |
| 473 | STRO | Sutro Biopharma, Inc. | 444.42M | -0.83% | 132,259 | 102.48M |
| 474 | AUNA | Auna S.A. | 443.34M | 0.84% | 112,408 | 1.30B |
| 475 | BBNX | Beta Bionics, Inc. | 442.93M | 1.94% | 314,499 | 100.25M |
| 476 | AURA | Aura Biosciences, Inc. | 438.47M | 0.96% | 141,922 | - |
| 477 | ALT | Altimmune, Inc. | 438.45M | - | 804,109 | 41.00K |
| 478 | EBS | Emergent BioSolutions Inc. | 437.95M | 1.07% | 182,444 | 742.90M |
| 479 | FLGT | Fulgent Genetics, Inc. | 437.86M | -4.11% | 151,501 | 322.67M |
| 480 | ANL | Adlai Nortye Ltd. | 434.32M | -2.16% | 349,052 | -1.35M |
| 481 | MYGN | Myriad Genetics, Inc. | 432.48M | -3.04% | 382,223 | 824.50M |
| 482 | VNDA | Vanda Pharmaceuticals Inc. | 430.31M | -0.14% | 356,124 | 216.11M |
| 483 | XOMA | XOMA Royalty Corporation | 428.73M | 3.81% | 151,945 | 52.15M |
| 484 | ANGO | AngioDynamics, Inc. | 426.41M | 0.59% | 250,315 | 313.73M |
| 485 | ARMP | Armata Pharmaceuticals, Inc. | 422.56M | -4.83% | 22,187 | 4.90M |
| 486 | CYH | Community Health Systems, Inc. | 422.34M | 1.77% | 641,336 | 12.49B |
| 487 | PACB | Pacific Biosciences of California, Inc. | 421.97M | -4.95% | 3,626,420 | 160.01M |
| 488 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.16M | 3.49% | 89,491 | - |
| 489 | NAUT | Nautilus Biotechnology, Inc. | 412.60M | 4.15% | 94,348 | - |
| 490 | IPSC | Century Therapeutics, Inc. | 410.67M | -0.22% | 1,101,195 | 109.16M |
| 491 | YDES | YD Bio Limited | 407.85M | 0.69% | 12,536 | 510.36K |
| 492 | ENTA | Enanta Pharmaceuticals, Inc. | 406.27M | 1.67% | 27,858 | 66.98M |
| 493 | KIDS | OrthoPediatrics Corp. | 405.98M | 0.31% | 39,070 | 236.35M |
| 494 | AUTL | Autolus Therapeutics plc | 396.55M | - | 1,673,054 | 75.39M |
| 495 | IRD | Opus Genetics, Inc. | 393.46M | 7.38% | 662,669 | 14.20M |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 392.30M | -0.14% | 1,158,655 | - |
| 497 | PBYI | Puma Biotechnology, Inc. | 391.24M | 2.40% | 172,701 | 228.37M |
| 498 | PRTC | PureTech Health plc | 391.19M | 4.65% | 1,541 | 6.39M |
| 499 | NRC | National Research Corporation | 389.19M | -0.87% | 29,217 | 137.39M |
| 500 | CGC | Canopy Growth Corporation | 387.76M | 5.29% | 7,656,698 | 203.04M |